Acod1 expression in cancer cells promotes immune evasion through the generation of inhibitory peptides

James H Schofield,Joseph Longo,Ryan D Sheldon,Emma Albano,Abigail E Ellis,Mark A Hawk,Sean Murphy,Loan Duong,Sharif Rahmy,Xin Lu,Russell G Jones,Zachary T Schafer,James H. Schofield,Ryan D. Sheldon,Abigail E. Ellis,Mark A. Hawk,Russell G. Jones,Zachary T. Schafer
DOI: https://doi.org/10.1016/j.celrep.2024.113984
IF: 8.8
2024-03-23
Cell Reports
Abstract:Schofield et al. report that cancer cells upregulate Acod1 as a survival strategy in response to αPD-1 therapy. Acod1hi cancer cells secrete inhibitory peptides that block the activation of naive CD8+ T cells. Loss of Acod1 resensitizes resistant tumors to αPD-1 ICB.
cell biology
What problem does this paper attempt to address?